APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 72 filers reported holding APTOSE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,488 | -96.2% | 11,700 | -96.6% | 0.00% | – |
| Q4 2022 | $199,106 | -99.9% | 343,286 | +0.8% | 0.00% | – |
| Q3 2022 | $202,649,000 | -20.2% | 340,586 | -0.5% | 0.00% | – |
| Q2 2022 | $253,936,000 | -72.8% | 342,186 | -50.1% | 0.00% | -100.0% |
| Q1 2022 | $933,039,000 | +0.7% | 686,058 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $926,178,000 | +24.7% | 686,058 | +101.4% | 0.00% | 0.0% |
| Q3 2021 | $742,477,000 | -34.3% | 340,586 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,130,746,000 | -44.4% | 340,586 | 0.0% | 0.00% | -66.7% |
| Q1 2021 | $2,035,001,000 | +36.4% | 340,586 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,491,767,000 | -27.0% | 340,586 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,043,516,000 | -4.9% | 340,586 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $2,149,098,000 | +116.3% | 340,586 | +103.6% | 0.00% | +100.0% |
| Q1 2020 | $993,679,000 | – | 167,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
| SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
| Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
| DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
| PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
| Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
| CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
| Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
| Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
| WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |